| |
As reported on August 17, 2006, the Board of Directors of The Gabelli Equity Trust Inc. (the
"Equity Trust") (NYSE:GAB) approved, subject to shareholder and other regulatory approvals, the
contribution of a portion of the Equity Trust's assets to a newly formed non-diversified,
closed-end investment company, The Gabelli Global Healthcare & WellnessRx
Trust (the "Healthcare & WellnessRx Trust"). All
of the Healthcare & WellnessRx Trust's common
stock would then be distributed to the common stockholders of the Equity Trust.
The Board of Directors recently approved the filing of a registration statement with the Securities
and Exchange Commission to include the following information about the proposed spin-off:
- The Equity Trust will fund the Healthcare & WellnessRx
Trust with approximately $60 million to $100 million of its cash and/or securities.
- The Equity Trust will distribute all of the shares of the Healthcare &
WellnessRx Trust pro rata to the common
stockholders of the Equity Trust.
- The Healthcare & WellnessRx Trust
will seek to have its shares listed on the New York Stock Exchange.
- The Healthcare & WellnessRx Trust
will seek long-term growth of capital by investing at least 80% of its assets in equity
securities of companies involved to a substantial extent in providing products, services
and/or equipment related to healthcare, medical, or lifestyle needs.
The transaction, which will be voted upon at the Equity Trust's Annual Meeting of Shareholders in May 2007,
would represent the third spin-off of a closed-end investment company by the Equity Trust. The number of
shares to be distributed and the record and distribution dates for the transaction will be announced at a
later time. The spin-off is expected to occur in late spring or early summer. The distribution will be
made only by means of a prospectus and this notice does not constitute an offer of any securities for sale.
The Gabelli Equity Trust Inc. is a non-diversified, closed-end management investment company with $2.1
billion in total assets whose primary investment objective is long term growth of capital. The Fund is
managed by Gabelli Funds, LLC, a subsidiary of GAMCO Investors, Inc. (NYSE:GBL) which is a publicly traded
NYSE listed company.
| |